SCHEMBL4637718

SCHEMBL4637718

NC(=O)C1=CC=CC=NN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15012524 0.71 CYP2C9 (0.31)
SCHEMBL29575931 0.66
SCHEMBL6528452 0.66
Water SCHEMBL28206745 0.64 POLB (0.30)
Hydrogen Sulfide SCHEMBL28207789 0.64 POLB (0.30)
Hydrochloric Acid SCHEMBL27832467 0.64 POLB (0.30)
Hydrochloric Acid SCHEMBL28642702 0.64 POLB (0.30)
Hydrochloric Acid SCHEMBL28208398 0.62
Hydrochloric Acid SCHEMBL28207816 0.62
SCHEMBL4637726 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130095-A9 COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-08-02 WO disclosed
CN-107207509-B Substituted bridged ring urea analogs as sirtuin modulators 葛兰素史密斯克莱知识产权(第2 号)有限公司 2020-04-21 CN disclosed
WO-2016126722-A1 3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS FORMA THERAPEUTICS, INC. (US) 2016-08-11 WO disclosed
WO-2016126725-A1 3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS FORMA THERAPEUTICS, INC. (US) 2016-08-11 WO disclosed
EP-1937272-A2 BENZODIAZEPINES AS HCV INHIBITORS Tibotec Pharmaceuticals Ltd. (IE) 2008-07-02 EP disclosed
WO-2007026024-A2 BENZODIAZEPINES AS HCV INHIBITORS TIBOTEC PHARMACEUTICALS LTD. (IE) 2007-03-08 WO disclosed